Clinical trial
A Prospective, Multicenter Clinical Trial Evaluating the Feasibility and Safety of Polymer Artificial Heart Valve for the Treatment of Mitral Valve Diseases
NCT07243184 is registered in ClinicalTrials.gov with Shanghai HeartEpoch Medical Technology Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Clinical Trial Evaluating the Feasibility and Safety of Polymer Artificial Heart Valve for the Treatment of Mitral Valve Diseases
- Lead sponsor
- Shanghai HeartEpoch Medical Technology Co., Ltd
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 19, 2025
- Completion date
- November 30, 2032
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe mitral valve regurgitation, severe mitral valve stenosis